Author: Pereckaitė, Laura; Dambrauskienė, Asta; Urbonienė, Daiva; Sadauskas, Saulius; Petrikonis, Kęstutis; Naudžiūnas, Albinas; Vitkauskienė, Astra
Title: SARS-CoV-2 Seroprevalence in Healthcare Workers of Kaunas Hospitals during the First Wave of the COVID-19 Pandemic Cord-id: 6ksbqji4 Document date: 2021_2_6
ID: 6ksbqji4
Snippet: Background and objective: Serologic testing is a useful additional method for the diagnosis of COVID-19. It is also used for population-based seroepidemiological studies. The objective of the study was to determine SARS-CoV-2 seroprevalence in healthcare workers of Kaunas hospitals and to compare two methods for specific SARS-CoV-2 antibody testing. Materials and Methods: A total of 432 healthcare workers in Kaunas hospitals were enrolled in this study. Each participant filled a questionnaire in
Document: Background and objective: Serologic testing is a useful additional method for the diagnosis of COVID-19. It is also used for population-based seroepidemiological studies. The objective of the study was to determine SARS-CoV-2 seroprevalence in healthcare workers of Kaunas hospitals and to compare two methods for specific SARS-CoV-2 antibody testing. Materials and Methods: A total of 432 healthcare workers in Kaunas hospitals were enrolled in this study. Each participant filled a questionnaire including questions about their demographics, contact with suspected or confirmed COVID-19, acute respiratory symptoms, and whether they contacted their general practitioner, could not come to work, or had to be hospitalized. Capillary blood was used to test for SARS-CoV-2 specific immunoglobulin G (IgG) and immunoglobulin M (IgM) a lateral flow immunoassay. Serum samples were used to test for specific IgG and IgA class immunoglobulins using semiquantitative enzyme-linked immunosorbent assay (ELISA) method. Results: 24.77% of study participants had direct contact with a suspected or confirmed case of COVID-19. A total of 64.81% of studied individuals had at least one symptom representing acute respiratory infection, compatible with COVID-19. Lateral flow immunoassay detected SARS-CoV-2 specific IgG class immunoglobulins in 1.16% of the tested group. Fever, cough, dyspnea, nausea, diarrhea, headache, conjunctivitis, muscle pain, and loss of smell and taste predominated in the anti-SARS-CoV-2 IgG-positive group. Using ELISA, specific IgG were detected in 1.32% of the tested samples. Diarrhea, loss of appetite, and loss of smell and taste sensations were the most predominant symptoms in anti-SARS-CoV-2 IgG-positive group. The positive percent agreement of the two testing methods was 50%, and negative percent agreement was 99.66%. Conclusions: 1.16% of tested healthcare workers of Kaunas hospitals were anti-SARS-CoV-2 IgG-positive. The negative percent agreement of the lateral flow immunoassay and ELISA exceeded 99%.
Search related documents:
Co phrase search for related documents- accurate rapid and acute infection diagnostic: 1, 2
- accurate rapid and acute phase: 1, 2
- accurate rapid and acute respiratory infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
- accurate rapid and long incubation period: 1
- accurate rapid and low prevalence: 1, 2, 3, 4
- accurate rapid and low sensitivity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- accurate rapid and low specificity: 1, 2, 3, 4, 5, 6
- accurate rapid testing and acute respiratory infection: 1, 2, 3
- accurate rapid testing and low sensitivity: 1, 2, 3, 4
- accurate rapid testing and low specificity: 1
- acute fever and long term immunity: 1
- acute fever and low respiratory tract: 1
- acute fever and low sensitivity: 1
- acute fever and low virulence: 1
- acute phase and low prevalence: 1, 2, 3, 4, 5, 6, 7
- acute phase and low sensitivity: 1, 2, 3, 4, 5, 6
- acute phase and low seroprevalence: 1
- acute phase and low specificity: 1, 2, 3
- acute respiratory infection and low specificity: 1, 2, 3, 4, 5, 6, 7, 8, 9
Co phrase search for related documents, hyperlinks ordered by date